PTN Post: Issue 20 (July 2017) July 7, 2017Check out the July 2017 issue of the PTN Post, the newsletter for the Pediatrics Trials Network — this issue highlights new research and new recommendations for pediatric research. We hope you enjoy it, and as always, we welcome your comments and feedback.
POPS Paradigm Explained August 25, 2016PTN studies managed via the POPS paradigm seek to determine the appropriate dosing of understudied drugs in children by using samples collected as part of regular care (for example, blood draws). The data collected provides valuable pharmacokinetic and dosing information for drugs in different pediatric age groups and special pediatric populations (such as obese children).
SCAMP Enrollment is Wrapping Up August 25, 2016Two years ago, the study site at the University of Florida–Jacksonville Shands Medical Centerwe enrolled SCAMP’s first patient. With remarkable effort from more than 50 study sites, including 5 in Canada, SCAMP will close enrollment by the end of 2016. Once the enrollment period ends, the study team will analyze the data and submit the clinical study report.
Lisinopril label change May 20, 2016The FDA changed the drug label for lisinopril to reflect findings from a study conducted by PTN investigators. Results from the study were published in the journal, Clinical Pharmacology &Therapeutics.
PTN MD, Micky Cohen-Wolkowiez, receives Young Investigator Award May 19, 2016Michael (Micky) Cohen-Wolkowiez, MD, PhD, director of the Duke Clinical Research Unit, has received the 2016 Young Investigator Award from the Pediatric Infectious Diseases Society (PIDS). The award recognizes a young physician whose research has generated outstanding contributions in the field of pediatric infectious diseases.Cohen-Wolkowiez is the author of more than 75 peer-reviewed publications and has ...
PTN lisinopril study and subsequent label change highlighted in DCRI News. May 12, 2016Pediatric Trials Network study results in label change for hypertension drug
May 11, 2016 – The change could affect the hundreds of children who are prescribed lisinopril after kidney transplants each year.
A study conducted by the Pediatric Trials Network (PTN) has resulted in a labelling change for a widely used drug.
Lisinopril is an angiotensin converting enzyme inhibitor that ...
PTN Gears up to Present at the 2016 Pediatric Academic Society (PAS) Meeting April 18, 2016PTN Investigators to present abstracts at the PAS Meeting in Baltimore, April 30-May 3
Here’s a sampling of presentations with more to come:
Platform Presentation: Sunday, May 1 at 4:15 PM–Dosing of antimicrobials in the neonatal in the NICU: Does clinical practice reflect published recommendations? M England, RG Greenberg, RH Clark, M Laughon, M Cohen-Wolkowiez, DK Benjamin Jr, and ...
NICHD Announces Research Funding Opportunity (U54) February 3, 2016Specialized Centers in Research in Pediatric Developmental Pharmacology (U54)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announces the re-competition of the Research in Pediatric Developmental Pharmacology Centers Program (RPDP).
The NICHD proposes to fund a limited number of research Centers that will provide an arena for multidisciplinary interactions between basic and clinical scientists interested in ...
Project babyTAPE Measures Up January 14, 2016On December 18, 10 days ahead of schedule, the PTN babyTAPE team enrolled its 2,000th participant.
On January 29, the babyTAPE databse was locked.
The data collected in the babyTAPE study will be used to develop, design, and validate a weight estimation tool, similar to what is pictured, specific to infants.
The study is chaired by Dr. Susan ...
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.